Skip to main content

Table 2 Baseline characteristics among MASLD individuals with prediabetes or diabetes by mortality status

From: Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes

Variables

Alive

N = 994

Deceased

N = 1163

p

Age, years

44.0 (36.0, 51.0)

62.0 (53.0, 68.0)

< 0.001

Men, n (%)

452 (51.3)

574 (50.6)

0.837

Ethnicity, n (%)

  

< 0.001

 Non-Hispanic White

254 (66.9)

531 (83.9)

 

 Non-Hispanic Black

252 (11.4)

243 (8.4)

 

 Mexican American

440 (10.2)

364 (4.5)

 

 Other ethnicities

48 (11.6)

25 (3.1)

 

Family income ratio, n (%)

  

0.992

 < 1.3

327 (16.6)

344 (16.9)

 

 1.3–3.5

487 (51.0)

595 (50.9)

 

 > 3.5

180 (32.4)

224 (32.2)

 

Married, n (%)

736 (78.7)

781(71.1)

0.042

Education level, n (%)

  

< 0.001

 <=12

726 (59.8)

934 (72.3)

 

 > 12

268 (40.2)

229 (27.7)

 

Current smoker, n (%)

172 (19.3)

247 (21.6)

0.504

SBP, mmHg

123.0 (113.0, 132.0)

134.0 (124.0, 148.0)

< 0.001

DBP, mmHg

78.0 (72.0, 85.0)

77.0 (71.0, 84.0)

0.345

BMI, kg/m2

29.8 (26.5, 34.4)

29.8 (26.4, 33.7)

0.794

WC, cm

102.2 (93.0, 110.5)

104.5 (97.0, 113.0)

0.001

FBG, mmol/L

5.7 (5.2, 6.2)

5.7 (5.2, 6.9)

0.079

HbA1c, %

5.6 (5.2, 5.9)

5.8 (5.4, 6.3)

< 0.001

TG, mmol/L

1.8 (1.2, 2.7)

2.0 (1.4, 2.9)

0.006

HDL-C, mmol/L

1.1 (0.9, 1.3)

1.1 (0.9, 1.3)

0.404

Creatinine, umol/L

97.2 (79.6, 106.1)

97.2 (88.4, 106.1)

0.002

PLT, 109/L

269.5 (228.9, 320.2)

261.5 (214.5, 307.5)

0.009

ALT, U/L

21.0 (15.0, 29.0)

17.0 (12.0, 23.0)

< 0.001

AST, U/L

21.0 (18.0, 26.0)

20.0 (17.0, 25.0)

0.056

FIB-4 > 1.3, n (%)

116 (8.3)

480 (41.6)

< 0.001

TyG index

9.0 (8.6, 9.6)

9.2 (8.8, 9.6)

0.001

TyG-BMI index

271.6 (239.3, 321.1)

277.7 (242.0, 320.4)

0.344

TyG-WHtR index

5.5 (4.9, 6.2)

5.8 (5.3, 6.5)

< 0.001

TyG-WWI index

98.9 (91.0, 107.3)

105.4 (98.6, 112.2)

< 0.001

TyG-WC index

929.1 (821.6, 1039.0)

972.1 (879.6, 1083.8)

< 0.001

Overweight or obesity, n (%)

895 (88.2)

1082 (92.5)

0.029

Hypertriglyceridemia, n (%)

505 (56.5)

720 (64.3)

0.027

High blood pressure, n (%)

436 (42.8)

858 (69.9)

< 0.001

Low HDL-C, n (%)

554 (57.8)

657 (60.1)

0.580

diabetes, n(%)

299 (26.3)

597 (44.0)

< 0.001

Heart attack, n (%)

19 (1.7)

118 (10.9)

< 0.001

Antihypertensive medications, n (%)

146 (15.8)

415 (34.0)

< 0.001

Lipid-lowering medications,

n (%)

32 (4.4)

84 (8.3)

0.020

Glucose-lowering medications, n (%)

57 (4.6)

165 (12.8)

< 0.001

  1. Data are displayed as the median (interquartile range) or unweighted frequency counts (weighted percentage) as appropriate. The Mann-Whitney test for continuous variables and the chi-square test for categorical variables were used in this analysis